An indolylquinoline derivative promotes apoptosis in human lung cancer cells by impairing mitochondrial functions

Chun Yen Liu, Pei Tsen Wu, Jing Ping Wang, Po Wei Fan, Chang Hung Hsieh, Chun Li Su, Chien Chih Chiu, Ching Fa Yao, Kang Fang*

*此作品的通信作者

研究成果: 雜誌貢獻期刊論文同行評審

10 引文 斯高帕斯(Scopus)

摘要

A number of effective anti-cancer drugs contain either indole or quinoline group. Compounds fused indole and quinoline moieties altogether as indolylquinoline were rarely reported as anti-cancer agents. We reported here that a synthetic indolylquinoline derivative, 3-((7-ethyl-1H-indol-3-yl)-methyl)-2-methylquinoline (EMMQ), inhibited the growth of human non-small cell lung cancer (NSCLC) cells in dose- and time-dependent manners. The cytotoxicity was mediated through apoptotic cell death that began with mitochondrial membrane potential interruption and DNA damage. EMMQ caused transient elevation of p53 that assists in cytochrome c release, cleavage of downstream PARP and procaspase-3 and mitochondria-related apoptosis. The degree of apoptotic cell death depends on the status of tumor suppressor p53 of the target cells. H1299 cells with stable ectopic expression of p53 induced cytotoxicity by disrupting mitochondria functions that differed with those transfected with mutant p53. Knocking-down of p53 attenuated drug effects. EMMQ suppressed the growth of A549 tumor cells in xenograft tumors by exhibiting apoptosis characteristics. Given its small molecular weight acting as an effective p53 regulator in NSCLC cells, EMMQ could be an addition to the current list of lung cancer treatment.

原文英語
頁(從 - 到)1471-1482
頁數12
期刊Apoptosis
20
發行號11
DOIs
出版狀態已發佈 - 2015 十一月 30

ASJC Scopus subject areas

  • 藥理
  • 藥學科學
  • 臨床生物化學
  • 細胞生物學
  • 生物化學(醫學)
  • 癌症研究

指紋

深入研究「An indolylquinoline derivative promotes apoptosis in human lung cancer cells by impairing mitochondrial functions」主題。共同形成了獨特的指紋。

引用此